Point-of-care testing (POCT) in pharmacies has grown from A1C and cholesterol screenings to testing for infectious diseases such as hepatitis C virus and HIV. POCT by pharmacists for influenza and streptococcal pharyngitis infection has been especially well received, along with the ability of pharmacists in certain states to dispense needed medications when those tests come back positive.

Maria G. Tanzi, PharmDMaria G. Tanzi, PharmD

The 2017 American College of Cardiology/American Heart Association guidelines on management of hypertension currently recommend use of thiazide diuretics as first-line agents.

Maria G. Tanzi, PharmD

In February, Eisai removed the weight-loss drug lorcaserin (Belviq, BelviqXR) from the market at FDA’s request.

Sonya Collins

FDA recently approved bempedoic acid (Nexletol), the first once-daily, oral nonstatin drug to lower LDL-C in nearly 20 years, as well as bempedoic acid and ezetimibe (Nexlizet), the first nonstatin combination drug ever approved.

Cara Aldridge Young

After a research article published in Lancet on March 11 indicated that use of ibuprofen may worsen COVID-19 symptoms, and the subsequent media attention, patients are wary of taking NSAIDs in case they may be infected with coronavirus.

Mary Warner